Driving impairment in depressed patients receiving long-term antidepressant treatment

Psychopharmacology

Volumn 188, Issue 1, 2006, Pages 84-91

  Wingen, Marleen ^a   Ramaekers, Johannes G ^a   Schmitt, Jeroen A J ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Antidepressants; Cognition; Depression; Driving performance

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; IRBESARTAN; LISINOPRIL; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADAPTATION; ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; DRIVING ABILITY; FEMALE; HAMILTON SCALE; HUMAN; LABORATORY TEST; LONG TERM EXPOSURE; MALE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; SCORING SYSTEM; STATISTICAL ANALYSIS; TASK PERFORMANCE;

ADRENERGIC UPTAKE INHIBITORS; ADULT; AUTOMOBILE DRIVING; CASE-CONTROL STUDIES; COGNITION; DEPRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FLICKER FUSION; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SEROTONIN UPTAKE INHIBITORS;

EID: 33747626493     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0471-7     Document Type: Article

References (32)

1. Amado-Boccara I, Gougoulis N, Poirier Littre MF, Galinowski A, Loo H (1995) Effects of antidepressants on cognitive functions: a review. Neurosci Biobehav Rev 19:479-493
2. Austin MP, Mitchell P, Goodwin GM (2001) Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 178:200-206
3. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, MacDonald TM (1998) Association of road-traffic accidents with benzodiazepine use. Lancet 352:1331-1336
4. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
5. Brookhuis KA, de Waard D, Mulder B (1994) Measuring driving performance by car-following in traffic. Ergonomics 37:427-434
6. Brunnauer A, Laux G (2003) Fahrtuchtigkeit und Antidepressiva. Psychiatr Prax 30(Suppl 2):S102-S105
7. Burt DB, Zembar MJ, Niederehe G (1995) Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol Bull 117:285-305
8. Conners CX (1992) Conners' continuous performnace test computer program user's guide. Multi-Health Systems, Toronto, Canada
9. Curran S (1990) Critical flicker fusion techniques in psychopharmacology. In: Hindmarch I, Stonier PD (eds) Human psychopharmacology. Wiley, Chichester
10. Curran S, Wattis JP (1998) Critical flicker fusion threshold: a useful research tool in patients with Alzheimers disease. Hum Psychopharmacol 13:337-355
11. Dornhoefer SM, Unema PJ, Velichkovsky BM (2002) Blinks, blanks and saccades: how blind we really are for relevant visual events. Prog Brain Res 140:119-131
12. Gerhard U, Hobi V (1984) Cognitive-psychomotor functions with regard to fitness for driving of psychiatric patients treated with neuroleptics and antidepressants. Neuropsychobiology 12:39-47
13. Grabe HJ, Wolf T, Gratz S, Laux G (1998) The influence of polypharmacological antidepressive treatment on central nervous information processing of depressed patients: implications for fitness to drive. Neuropsychobiology 37:200-204
14. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296
15. Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH (1994) Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 5:591-598
16. Louwerens JW, Gloerich ABM, De Vries G, Brookhuis KA, O'Hanlon JF (1987) The relationship between drivers' blood alcohol concentration (BAC) and actual driving performance during high speed travel. In: Noordzij PC, Roszbach R (eds) Alcohol, drugs and traffic safety. Elsevier, Amsterdam, pp 183-186
17. McNair DM, Lorr M, Droppleman LF (1992) Manual for the profile of mood states (revised). Educational and Industrial Testing Service, San Diego CA
18. Mulder-Hajonides van der Meulen WREH (1981) Measurement of subjective sleep quality. Proceedings of the international European sleep conference. Elsevier, Amsterdam, The Netherlands
19. O'Hanlon JF (1984) Driving performance under the influence of drugs: rationale for, and application of, a new test. Br J Pharmacol 18(Suppl 1):121S-129S
20. O'Hanlon J, Robbe HWJ, Vermeeren A, VanLeeuwen C, Danjou PE (1998) Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. J Clin Psychopharmacol 18:212-221
21. Ramaekers JG (2003) Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry 64:20-29
22. Ramaekers JG, Ansseau M, Muntjewerff ND, Sweens JP, O'Hanlon JF (1997) Considering the P450 cytochrome system as determining combined effects of antidepressants and benzodiazepines on actual driving performance of depressed outpatients. Int Clin Psychopharmacol 12:159-169
23. Ramaekers G, Lamers J, Verhey F, Muntjewerff D, Mobbs E, Sanders N, Lewis M, Lockton A (2002) A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic. Psychopharmacology (Berl) 159:203-210
24. Ray WA, Fought RL, Decker MD (1992) Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 136:873-883
25. Rey A (1964) L'examen psychologique dans les cas d'encéphalopathie traumatique. Presses Universitaires de France, Paris, France
26. Riedel WJ, Eikmans K, Heldens A, Schmitt JA (2005) Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment. J Psychopharmacol 19:12-20
27. Schmitt JA, Ramaekers JG, Kruizinga MJ, van Boxtel MP, Vuurman EF, Riedel WJ (2002a) Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man. J Psychopharmacol 16:207-214
28. Schmitt JA, Riedel WJ, Vuurman EF, Kruizinga M, Ramaekers JG (2002b) Modulation of the critical flicker fusion effects of serotonin reuptake inhibitors by concomitant pupillary changes. Psychopharmacology (Berl) 160:381-386
29. Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643-662
30. Vaa T (2003) Impairments, diseases, age and their relative risks of accident involvement: results from a meta-analysis. IMMORTAL-deliverable 1.1 Project funded by the European Commission under the transport RTD Programme of the 5th framework programme
31. Wechsler D (1981) The measurement and appraisal of adult intelligence. Williams and Wilkins, Baltimore
32. Zakzanis KK, Leach L, Kaplan E (1998) On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry Neuropsychol Behav Neurol 11:111-119